Veptr II
Total Payments
$26,199
Transactions
10
Doctors
7
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $44.75 | 3 | 2 |
| 2023 | $70.32 | 2 | 2 |
| 2022 | $84.02 | 3 | 3 |
| 2021 | $26,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $26,000 | 2 | 99.2% |
| Food and Beverage | $199.09 | 8 | 0.8% |
Payments by Type
Research
$26,000
2 transactions
General
$199.09
8 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Long Term Outcomes of the VEPTR device in Patients with Early Onset Scoliosis | Medical Device Business Services, Inc. | $26,000 | 0 |
Top Doctors Receiving Payments for Veptr II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Valley Forge, PA | $26,000 | 2 |
| , M.D | Orthopaedic Surgery | San Diego, CA | $35.16 | 1 |
| , MD | Orthopaedic Surgery | Durham, NC | $35.16 | 1 |
| , MD | Orthopaedic Surgery | St Petersburg, FL | $29.64 | 1 |
| , M.D | Pediatric Orthopaedic Surgery | Loma Linda, CA | $27.19 | 1 |
| , M.D | Orthopaedic Surgery | Reno, NV | $27.19 | 1 |
| , M.D | Orthopaedic Surgery | East Setauket, NY | $26.98 | 2 |
| Dorian Cohen | Orthopaedic Surgery | Stony Brook, NY | $17.77 | 1 |
Ad
Manufacturing Companies
- Medical Device Business Services, Inc. $26,000
- DePuy Synthes Sales Inc. $199.09
Product Information
- Type Device
- Total Payments $26,199
- Total Doctors 7
- Transactions 10
About Veptr II
Veptr II is a device associated with $26,199 in payments to 7 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2021 to 2024. In 2024, $44.75 was paid across 3 transactions to 2 doctors.
The most common payment nature for Veptr II is "Unspecified" ($26,000, 99.2% of total).
Veptr II is associated with 1 research study, including "Long Term Outcomes of the VEPTR device in Patients with Early Onset Scoliosis" ($26,000).